跳轉至內容
Merck
  • Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.

Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.

The Journal of biological chemistry (2007-02-08)
Mihaela Necula, Rakez Kayed, Saskia Milton, Charles G Glabe
摘要

Alzheimer disease is characterized by the abnormal aggregation of amyloid beta peptide into extracellular fibrillar deposits known as amyloid plaques. Soluble oligomers have been observed at early time points preceding fibril formation, and these oligomers have been implicated as the primary pathological species rather than the mature fibrils. A significant issue that remains to be resolved is whether amyloid oligomers are an obligate intermediate on the pathway to fibril formation or represent an alternate assembly pathway that may or may not lead to fiber formation. To determine whether amyloid beta oligomers are obligate intermediates in the fibrillization pathway, we characterized the mechanism of action of amyloid beta aggregation inhibitors in terms of oligomer and fibril formation. Based on their effects, the small molecules segregated into three distinct classes: compounds that inhibit oligomerization but not fibrillization, compounds that inhibit fibrillization but not oligomerization, and compounds that inhibit both. Several compounds selectively inhibited oligomerization at substoichiometric concentrations relative to amyloid beta monomer, with some active in the low nanomolar range. These results indicate that oligomers are not an obligate intermediate in the fibril formation pathway. In addition, these data suggest that small molecule inhibitors are useful for clarifying the mechanisms underlying protein aggregation and may represent potential therapeutic agents that target fundamental disease mechanisms.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
溴化十六烷基三甲铵, ≥98%
Sigma-Aldrich
溴化十六烷基三甲铵, for molecular biology, ≥99%
Sigma-Aldrich
褪黑素, powder, ≥98% (TLC)
Sigma-Aldrich
溴化十六烷基三甲铵, BioXtra, ≥99%
Sigma-Aldrich
吲哚美辛, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
新亚铜试剂, ≥98%
Sigma-Aldrich
芹菜素, ≥95.0% (HPLC)
Sigma-Aldrich
溴化十六烷基三甲铵, BioUltra, for molecular biology, ≥99.0% (AT)
Sigma-Aldrich
邻香草醛, 99%
Sigma-Aldrich
四氢噻吩, 99%
Sigma-Aldrich
溴化十四烷基三甲基铵, ≥99%
Sigma-Aldrich
杨梅黄素, ≥96.0%, crystalline
Sigma-Aldrich
杨梅黄素, ≥96.0% (HPLC)
Sigma-Aldrich
吲哚美辛, meets USP testing specifications
Sigma-Aldrich
5-羟基对萘醌, 97%
Sigma-Aldrich
去甲二氢愈创木酸, ≥97.0% (HPLC)
Sigma-Aldrich
酚红 溶液, 0.5%, liquid, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
酚红, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
伊红 Y 溶液, 5 wt. % in H2O
Sigma-Aldrich
酚红, ACS reagent
Sigma-Aldrich
伊红 Y 二钠盐, certified by the Biological Stain Commission
Sigma-Aldrich
伊红 Y 二钠盐, Dye content ≥85 %
Sigma-Aldrich
溴化十六烷基三甲铵, ≥96.0% (AT)
Supelco
溴化十六烷基三甲铵, suitable for ion pair chromatography, LiChropur
Sigma-Aldrich
溴化十四烷基三甲基铵, 98% (AT)
Supelco
溴化十六烷基三甲铵, analytical standard
Supelco
溴化十四烷基三甲基铵, suitable for ion pair chromatography, LiChropur, ≥99.0% (AT)